Hyundai Glovis has won international certification for healthcare logistics and is ready to muscle into the global healthcare logistics market, which is dominated by multinational logistics companies.
Hyundai Glovis announced on Dec. 7 that it won ISO 13485 certification from the British Royal Standards Institute (BSI) on Dec. 6
ISO 13485 is an international standard established by the International Organization for Standardization (ISO). The certification means that a company’s quality control system for medical devices management meets international standards and is compliant with all rules and policies associated with ISO 13485. The certification is essential to companies that provide services related to medical devices in the global market
Having earned an ISO 13485 registration, Hyundai Glovis plans to take aggressive sales activities in the global healthcare logistics market, which has been led by multinational companies such as DHL and FedEx.
Recently, demand for air transport of medical products has been on the decline as producers of healthcare products are opting for sea transport to reduce logistics costs.
Hyundai Glovis is planning to find new clients in the fields of biotech and medical devices through marketing that uses Hyundai Glovis' reliability and brand.
In particular, it developed detailed strategies to provide customized logistics services tailored to the needs of healthcare companies, which tend to manufacture a large number of products in small batches.
"We will establish ourselves as a logistics business specializing in healthcare based on our integrated logistics system," a company official said.
Hyundai Glovis will also expand its infrastructure, including the operation of a global joint logistics center, in order to create synergy between healthcare and other logistics fields.
In the second half of next year, it will further expand its healthcare logistics business to bio and clinical drugs by obtaining additional KSGP certification, which is a standard for quality control and storage of medicines in Korea.
The domestic third-party logistics (3PL) market for healthcare companies centered on medical devices and medicine is estimated at worth about 310 billion won.